Notice we are starting to post MSL and marketing jobs, but also noticed crickets with Amgen on the product. They don't even bring it up at dermatology conferences and their MSL team doesn't mention it. Not sure they even have TLLs.
Are we getting ready to have this returned to us? Can we move it alone given how entrenched Sanofi and Regeneron are with their injectable and how entrenched Abbvie with their oral?
Just getting a feeling Amgen is getting ready to rid themselves of this now that it's 36 months late. Lord knows they have walked away from dermatology before and the market still hates them.
Are we getting ready to have this returned to us? Can we move it alone given how entrenched Sanofi and Regeneron are with their injectable and how entrenched Abbvie with their oral?
Just getting a feeling Amgen is getting ready to rid themselves of this now that it's 36 months late. Lord knows they have walked away from dermatology before and the market still hates them.